Literature DB >> 9612191

Photodynamic therapy of brain tumors.

E A Popovic1, A H Kaye, J S Hill.   

Abstract

Photodynamic therapy (PDT) for the treatment of a variety of brain tumors, particularly gliomas, has been extensively investigated in laboratory studies and has been studied in clinical trials. The main advantage of PDT lies in its ability to select out tumor cells that are infiltrating brain parenchyma and that are responsible for local tumor recurrence, the major therapeutic dilemma in the treatment of gliomas. PDT has been shown to be safe clinically but adequate trials have yet to be undertaken to prove its efficacy and much work remains to be done to optimize treatment. The laboratory studies and clinical trials involving PDT in the treatment of cerebral tumors, particularly the commonest brain tumors, gliomas, are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9612191     DOI: 10.1089/clm.1996.14.251

Source DB:  PubMed          Journal:  J Clin Laser Med Surg        ISSN: 1044-5471


  9 in total

1.  Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery?

Authors:  Yu Cheng; Joseph D Meyers; Richard S Agnes; Tennyson L Doane; Malcolm E Kenney; Ann-Marie Broome; Clemens Burda; James P Basilion
Journal:  Small       Date:  2011-06-01       Impact factor: 13.281

2.  Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids.

Authors:  Steen J Madsen; Chung-Ho Sun; Bruce J Tromberg; Henry Hirschberg
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

3.  Induction of cytotoxicity by photoexcitation of TiO2 can prolong survival in glioma-bearing mice.

Authors:  Chao Wang; Shouqiang Cao; Xinxin Tie; Bo Qiu; Anhua Wu; Zhihong Zheng
Journal:  Mol Biol Rep       Date:  2010-03-30       Impact factor: 2.316

Review 4.  Current concepts in gastrointestinal photodynamic therapy.

Authors:  J Webber; M Herman; D Kessel; D Fromm
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

5.  Acute morphological sequelae of photodynamic therapy with 5-aminolevulinic acid in the C6 spheroid model.

Authors:  Pitr Zelenkov; Reinhold Baumgartner; Karl Bise; Michael Heide; Richard Meier; Susanne Stocker; Ronald Sroka; Roland Goldbrunner; Walter Stummer
Journal:  J Neurooncol       Date:  2006-09-27       Impact factor: 4.130

6.  Dual Receptor-Targeted Theranostic Nanoparticles for Localized Delivery and Activation of Photodynamic Therapy Drug in Glioblastomas.

Authors:  Suraj Dixit; Kayla Miller; Yun Zhu; Emilie McKinnon; Thomas Novak; Malcolm E Kenney; Ann-Marie Broome
Journal:  Mol Pharm       Date:  2015-08-24       Impact factor: 4.939

7.  ALA- and ALA-ester-mediated photodynamic therapy of human glioma spheroids.

Authors:  Henry Hirschberg; Chung-Ho Sun; Bruce J Tromberg; Steen J Madsen
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

Review 8.  Photodynamic therapy.

Authors:  T J Dougherty; C J Gomer; B W Henderson; G Jori; D Kessel; M Korbelik; J Moan; Q Peng
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

9.  Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue.

Authors:  L Lilge; M Portnoy; B C Wilson
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.